Answers are grounded in this paper and cite their sources.
and tumors express altered patterns of gene expression, the actual activity of most regulatory genes is similar to normal cells. Resistance develops because the biochemical pathways involved are complex and regulated by combinations of both stimulatory and inhibitory factors; many affected by therapy, and some of these affected genes are susceptible to altered patterns of expression having the potential to reverse the effects of the intended treatment. Our studies have shown that the evaluation of non-targeted genes, following what was believed to be specific gene therapy, suggests that tumors frequently alter their dependence on the initially targeted gene products, by relying upon others through the process of compensation [1]. Just as bacteria and viruses mutate to evade antibiotic and antiviral agents, tumor cells are under similar selective pressure to evade therapy, whether chemical (chemotherapy), hormonal (deprivation), radiologically induced, or that based on suppression of gene translation (including the use of antisense oligonucleotides [oligos]). While oligo based therapy is already in clinical trials, the unintended compensatory consequences of intervention are poorly understood, and could contribute to the emergence and selection of more aggressive tumor cells.
No takes yet. Share an insight, caveat, or question.
Marvin Rubenstein (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: